Neurotoxins: Free radical mechanisms and melatonin protection

Current Neuropharmacology

Volumn 8, Issue 3, 2010, Pages 194-210

  Reiter, Russel J ^a   Manchester, Lucien C ^a   Tan, Dun Xian ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

6 hydroxydopamine; Aminolevulinic acid; Cyanide; Domoic acid; Kainic acid; Melatonin; Metals; Methamphetamine; Polychlorinated biphenyls; Rotenone; Toluene

Indexed keywords

ALUMINUM; AMINOLEVULINIC ACID; CADMIUM; CHROMIUM; COBALT; COPPER; CYANIDE; DOMOIC ACID; FREE RADICAL; IRON; KAINIC ACID; LEVODOPA; MELATONIN; MERCURY; METAL; METHAMPHETAMINE; NEUROTOXIN; NICKEL; OXIDOPAMINE; POLYCHLORINATED BIPHENYL; ROTENONE; TOLUENE; VANADIUM;

ACUTE INTERMITTENT PORPHYRIA; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CELL; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; DNA DAMAGE; ELECTRON; GLIA; HUMAN; MACROMOLECULE; METABOLITE; MITOCHONDRION; MOTOR DYSFUNCTION; NECROSIS; NERVE CELL; NITROSATIVE STRESS; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PARKINSON DISEASE;

EID: 78549240952     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015910792246236     Document Type: Article

References (278)

1. Abdallah, G.M., El-Sayed, E.S., Abo-Salem, O.M. Effect of lead toxicity on conenzyme Q levels in rat tissues. Food Chem. Toxicol., in press.
2. Abd-Elghaffar, S.Kh., El-Sokkary, G.H., Sharkawy, A.A. (2005) Aluminum-induced neurotoxicity and oxidative damage in rabbits: protective effects of melatonin. Neuroendocrinol. Lett., 26, 609-619.
3. Acuna-Castroviejo, D., Coto-Montes, A., Monti, M.G., Ortiz, G.G., Reiter, R.J. (1997) Melatonin is protective against MPTP-induced striatal and hippocampal lesions. Life Sci., 60, PL23-PL29.
4. Acuna-Castroviejo, D., Escames, G., Carazo, A., Leon, J., Khaldy, H., Reiter, R.J. (2002) Melatonin, mitochondrial homeostasis and mitochondrial-related diseases. Curr. Top. Med. Chem., 2, 153-166.
5. Acuna-Castroviejo, D., Escames, G., Lopez, L.C., Hitos, A.B., Leon, J. (2005) Melatonin and nitric oxide: two required antagonists for mitochondrial homeostasis. Endocrine, 27, 159-168.
6. Agez, L., Laurent, V., Guerrero, H.Y., Pevet, P., Masson-Pevet, M., Gauer, F. (2009) Endogenous melatonin provides an effective circadian message to both the suprachiasmatic nuclei and the pars tuberalis of the rat. J. Pineal Res., 46, 95-105.
7. Agular, L.M., Vasconcelos, S.M., Sausa, F.C., Vaina, G.S. (2002) Melatonin reverses neurochemical alterations induced by 6-OHDA in rat striatum. Life Sci., 70, 1041-1051.
8. Akcay, Y.D., Yalcin, A., Sozmen, E.Y. (2005) The effect of melatonin on lipid peroxidation and nitrite/nitrate levels, and on superoxide dismutase and catalase activities in kainic acid-induced injury. Cell. Mol. Biol. Int., 10, 321-326.
9. Ali, S.F., Martin, J.I., Black, M.D., Itzhak, Y. (1999) Neuroprotective role of melatonin in methamphetamine and 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity. Ann. N.Y. Acad. Sci., 939, 119.
10. Ananth, C., Gopalakrishnakone, P., Kaur, C. (2003) Protective role of melatonin in domoic acid-induced neuronal damage in the hippocampus of adult rats. Hippocampus, 13, 375-387.
11. Antolin, I., Rodriguez, C., Sainz, R.M., Mayo, J.C., Uria, H., Kotler, M.L., Rodriguez-Colunga, M.J., Tolivia, D., Menendez-Pelaez, A. (1996) Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB J., 10, 882-890.
12. Arendt, J. (2000) Melatonin, circadian rhythms and sleep. New Engl. J. Med., 343, 1114-1116.
13. Arnao MB, Hernandez-Ruiz, J. (2009) Chemical stress by different agents affects the melatonin content of barley roots. J Pineal Res., 46, 295-299.
14. Arnao, M.D., Hernandez-Ruiz, J. (2009) Protective effect of melatonin against chlorophyll degradation during the senescence of barley leaves. J. Pineal Res., 46, 58-63.
15. Aydin, K., Kirkan, S., Sarwar, S., Okur, O., Balaban, E. (2009) Smaller gray matter volumes in frontal and parietal cortices of solvent abusers correlated with cognitive deficits. Am. J. Neuroradiol., 30, 1922-1928.
16. Bahkit, C., Morgan, M.E., Peat, M.A., Gibb, J.W. (1981) Longterm effects of methamphetamine on the synthesis and the metabolism of 6-hydroxytryptamine in various regions of the rat brain. Neuropharmacology, 20, 1135-140.
17. Bandyopadhyay, D., Biswas, K., Bandyopadhyay, U., Reiter, R.J., Banerjee, R.K. (2000) Melatonin protects against stress-induced gastric lesions by scavenging hydroxyl radicals. J. Pineal Res., 29, 143-151.
18. Barlow-Walden, L.R., Reiter, R.J., Abe, M., Pablos, M.I., Menendez-Pelaez, A., Chen, L.D. (1995) Melatonin stimulates brain glutathione peroxidase activity. Neurochem. Int., 26, 497-502.
19. Baydas, G., Reiter, R.J., Nedzvetskii, V.S., Yasar, A., Tuzcu, M., Ozveren, F., Canatan, H. (2003) Melatonin protects the central nervous system of rats against toluene-containing thinner intoxication by reducing reactive gliosis. Toxicol. Lett., 137, 169-174.
20. Benitez-King, G., Anton-Tay, F. (1993) Calmodulin mediates melatonin cytoskeletal effects. Experientia, 49, 635-641.
21. Betarbet, R., Sherer, T.B., MacKenzie G., Garcia-Osuna, M., Panov, A.V., Greenamyre, J.T. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci., 3, 1301-1306.
22. Betarbet, R., Canet-Aviles, R.M., Sherer, T.B., Mastroberardino, P.G., McLendon, C., Kim, J.H., Lund, S., Na, H.M., Taylor, G., Bence, N.F., Kopito, R., Seo, B.B., Yagi, T., Yagi, A., Klinefelter, G., Cookson, M.R., Greenamyre, J.T. (2006) Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-I, alpha-synuclein, and ubiquitin-proteasome system. Neurobiol. Dis., 22, 404-420.
23. Betarbet, R., Greenamyre, J.T. (2007) Parkinson's disease: animal models. Handb. Clin. Neurol. 83, 265-287.
24. Bettahi, I., Pozo, D., Osuna, C., Reiter, R.J., Acuna-Castroviejo, D., Guerrero, J.M. (1996) Melatonin reduces nitric oxide synthase activity in the rat hypothalamus. J. Pineal Res., 20, 205-210.
25. Blanchard, B., Pompon, D., Ducrocq, C. (2000) Nitrosation of melatonin by nitric oxide and peroxynitrite. J. Pineal Res., 29, 184-192.
26. Blask, D.E., Dauchy, R.T., Brainard, G.C., Hanifin, J.P. (2009) Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: consequences of its disruption by light at night in rats and women. Integr. Cancer Ther., 8, 347-353.
27. Blask, D.E., Dauchy, R.T., Sauer, L.A. (2005) Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Endocrine, 27, 179-188.
28. Blask, D.E., Sauer, L.A., Dauchy, R.T. (2002) Melatonin as a chronobiotic/anticancer agent: cellular, biochemical and molecular mechanisms of action and implications for circadian-based cancer therapy. Curr. Top. Med. Chem., 2, 113-132.
29. Borah, A., Mohanakumar, K.P. (2009) Melatonin inhibits 6-hydroxydopamine production in the brain to protect against experimental parkinsonism in rodents. J. Pineal Res., 47, 293-300.
30. Breen, A.P., Murphy, J.A. (1995) Reactions of oxyradicals with DNA. Free Radic. Biol. Med., 18, 1033-1077.
31. Burke, R.E. (1998) Programmed cell death and Parkinson's disease. Mov. Disord., 13, 17-23.
32. Burkhardt, S., Reiter, R.J., Tan, D.X., Hardeland, R., Cabrera, J., Karbownik, M. (2001) DNA oxidatively damaged by chromium (III) and H2O2 is protected by the antioxidants melatonin, N1-acetyl-N2-formyl-5-methoxykynuramine, resveratrol and uric acid. Int. J. Biochem. Mol. Biol., 33, 775-783.
33. Caballero, B., Vega-Naredo, I., Sierra, V., Huidobro-Fernandez, C., Soria-Valles, C., De Gonzalo-Calvo, D., Tolivia, D., Pallas, M., Camins, A., Rodriguez-Colunga, M.J., Coto-Montes, A. (2009) Melatonin alters cell death processes in response to age-related oxidative stress in the brain of senescence-accelerated mice. J. Pineal Res., 46, 106-114.
34. Cadet, J.L., Sheng, P., Ali, S., Rothman, R., Carlson, E., Epstein, C. (1994) Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J. Neurochem., 62, 380-383.
35. Cagnacci, A., Cannoletta, M., Renza, A., Baldassari, F., Arangino, S., Volpe, A. (2005) Prolonged melatonin administration decreases nocturnal blood pressure in women. Am. J. Hypertens., 18, 1614-1618.
36. Cannon, J.R., Tapias, V., Na, H.M., Honick, A.S., Drolet, R.E., Greenamyre, J.T. (2009) A highly reproducible rotenone model of Parkinson's disease. Neurobiol. Dis., 34, 279-290.
37. Carneiro, R.C.G., Reiter, R.J. (1997) Melatonin protects against lipid peroxidation induced by δ-aminolevulinic acid in rat cerebellum, cortex and hippocampus. Neuroscience, 82, 293-299.
38. Carretero, M., Escames, G., Lopez, L.C., Venegas, C., Dayoub, J.C., Garcia, L., Acuna-Castroviejo, D. (2009) Long-term melatonin administration protects brain mitochondria from aging. J. Pineal Res., 47, 192-200.
39. Carrillo-Vico, A., Guerrero, J.M., Lardone, P.J., Reiter, R.J. (2005) A review of the multiple actions of melatonin on the immune system. Endocrine, 27, 189-200.
40. Carrillo-Vico, A., Reiter, R.J., Lardone, P.J., Herrera, J.L., Fernandez-Montesinos, R., Guerrero, J.M., Pozo, D. (2006) The modulatory role of melatonin in immune responsiveness. Curr. Opin. Invest. Drugs, 7, 423-431.
41. Chahbauni, M., Escames, G., Venegas, C., Sevilla, B., Garcia, J.A., Lopez, L.C., Munoz-Hoyos, A., Molina-Carballo, A., Acuna-Castroviejo, D. (2010) Melatonin treatment normalizes plasma proinflammatory cytokines and nitrosative/oxidative stress in patients suffering from Duchenne muscular dystrophy. J. Pineal Res., 48, 282-289.
42. Chandrasekaran, A., Ponnambalam, G., Kaur, C. (2004) Domoic acid-induced neurotoxicity in the hippocampus of adult rats. Neurotox. Res., 6, 105-117.
43. Chang, H.M., Huang, Y.L., Lan, C.T., Wu, U.I., Hu, M.E., Youn, S.C. (2008) Melatonin preserves superoxide dismutase activity in hypoglossal motoneurons of adult rats following peripheral nerve injury. J. Pineal Res., 44, 172-180.
44. Chemineau, P., Gillaume, D., Migaud, M., Thiery, J.C., Pellicer-Rubio, M.T., Malpaux, B. (2008) Seasonality of reproduction in mammals: intimate regulatory mechanism and practical implications. Reprod. Domest. Anim., 43 (Suppl. 2), 40-47.
45. Chetsawang, B., Chetsawang, J., Govitrapong, P. (2009) Protections against cell death and sustained tyrosine hydroxylase phosphorylation in hydrogen peroxide and MPP+-treated human neuroblastoma cells with melatonin. J. Pineal Res., 46, 36-42.
46. Chetsawang, B., Govitrapong, P., Ebadi, M. (2004) The neuroprotective effect of melatonin against the induction of c-Jun phosphorylation by 6-hydroxydopamine in SK-N-SH cells. Neurosci. Lett., 371, 205-208.
47. Choi, W.I., Han, S.Z. (2002) Effects of melatonin on KCN-induced neurodegeneration in mice. Int. J. Neurosci., 112, 187-194.
48. Choi, W.S., Yoon, S.Y., Oh, T.H., Choi, E.J., O'Malley, K.I., Oh, Y.J. (1999) Two distinct mechanisms are involved in 6-hydroxydopamine-and MPP+-induced dopaminergic cell death: role of caspases, ROS and JNK. J. Neurosci. Res., 57, 86-94.
49. Chuang, J.I., Chen, S.T., Chang, Y.H., Jen, L.S. (2001) Alteration of Bcl-2 expression in the nigrostriatal system after kainate injection with or without melatonin co-treatment. J. Chem. Neuroanat., 21, 215-223.
50. Chung, S.Y., Han, S.H. (2003) Melatonin attenuates kainic-acidinduced hippocampal neurodegeneration and oxidative stress through microglial inhibition. J. Pineal Res., 34, 95-102.
51. Cos, S., Gonzalez, A., Martinez-Campa, C., Mediavilla, M.D., Alonso-Gonzalez, C., Sanchez-Barcelo, E. (2006) Estrogensignaling pathway: a link between breast cancer and melatonin oncostatic actions. Cancer Detect. Prev., 30, 18-28.
52. Costall, B., Naylor, R.J. (1975) Neuropharmacological studies on D145 (1, 3-dimethyl-5-aminoadamantan). Psychopharmacologic, 49, 53-56.
53. Coulom, H., Birman, S. (2004) Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster. J. Neurosci., 24, 10993-10998.
54. Coyle, J.T., Puttfarcken, P. (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science, 262, 689-695.
55. Cubelis, J.F., Rayport, S., Rajendran, G., Sulzer, D. (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci., 14, 260-271.
56. Dabbeni-Sala, F., Di Santo, S., Franceschini, D., Shaper, S.D., Guisti, P. (2001) Melatonin protects against 6-OHDA-indcued neurotoxicity in rats: a role for mitochondrial complex I activity. FASEB J., 15, 164-170.
57. Dabbeni-Sala, F., Floreani, M., Franceschini, D., Skaper, S.D., Giusti, P. (2001) Kainic acid induces mitochondrial oxidative phosphorylation enzyme dysfunction in cerebellar granule neurons: protective effects of melatonin and GSH ethyl ester. FASEB J., 15, 1786-1788.
58. Das, A., Belagodu, A., Swapan, R., Reiter, R.J., Banik, N. (2008) Cytoprotective effects of melatonin on C6 astroglial cells exposed to glutamate excitotoxicity and oxidative stress. J. Pineal Res., 45, 117-124.
59. Demasi, M., Penatti, C., De Lucia, R., Benhara, E. (1996) The prooxidant effect of 5-aminolevulinic acid in the brain tissue of rats: implications in neuropsychiatric manifestations in porphyrias. Free Radic. Biol. Med., 4, 155-161.
60. Dubbels, R., Reiter, R.J., Klenke, E., Goebel, A., Schnakenberg, E., Ehlers, C., Schiwara, H.W., Schloot, W. (1995) Melatonin in edible plants identified by radioimmunoassay and by high performance liquid chromatography-mass spectrometry. J. Pineal Res., 18, 28-31.
61. Dubocovich, M., Markowska, M. (2005) Functional MT1 and MT2 melatonin receptors in mammals. Endocrine, 27, 101-110.
62. Ebadi, M., Srinivasan, S.K., Baxi, M.D. (1996) Oxidative stress and antioxidant therapy in Parkinson's disease. Prog. Neurobiol., 48, 1-49.
63. Ebelt, H., Peschke, D., Brömme, H.J., Mörke, W., Blume, R., Peschke, E. (2000) Influence of melatonin on free radical-induced changes in rat pancreatic beta-cells in vitro. J. Pineal Res., 28, 65-72.
64. El-Sokkary, G.H., Kamel, E.S., Reiter, R.J. (2003) Prophylactic effect of melatonin in reducing lead-induced neurotoxicity in the rat. Cell. Mol., Biol. Lett., 8, 461-470.
65. Ersahin, M., Sehirki, O., Toklum H.Z., Suleymanoglu, S., Emekli-Alturfan, E., Yarat, A., Tatidede, E., Yeger, B.C. (2009) Melatonin improves cardiovascular function and ameliorates renal, cardiac and cerebral damage in rats with renovascular hypertension. J. Pineal Res., 47, 97-106.
66. Ersahin, E., Toklu, H.Z., Cetinel, S., Yuksel, M., Yegen, B.C., Sener, G. (2009) Melatonin reduces experimental subarachnoid hemorrhage-induced oxidative brain damage and neurological symptoms. J. Pineal Res., 46, 324-332.
67. Esparza, J.L., Gomez, M., Nogues, M.R., Paternain, J.L., Mallol, J., Domingo, J.L. (2005) Melatonin reduces oxidative stress and increases gene expression in the cerebral cortex and cerebellum o f aluminum-exposed rats. J. Pineal Res., 39, 129-136.
68. Esparza, J.L., Gomez, M., Romeu, M., Mulero, M., Sanchez, D.J., Mallol, J., Domingo, J.L. (2003) Aluminum-induced pro-oxidant effects in rats: protective role of melatonin. J. Pineal Res., 35, 32-39.
69. Fisher, S.P., Davidson, K., Kulia, A., Sugden, D. (2008) Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat. J. Pineal Res., 45, 125-132.
70. Fukutomi, J., Fukuda, A., Fukuda, S., Hara, M., Terada, A., Yoshida, M. (2006) Scavenging activity of indole compounds against cisplatin-induced reactive oxygen species. Life Sci., 80, 254-257.
71. Garcia-Allegue, R., Madrid, J.A., Sanchez-Vazquez, F.J. (2001) Melatonin rhythms in European sea bass plasma and eye: influence of seasonal photoperiod and temperature. J. Pineal Res., 31, 68-75.
72. Garcia, T., Esparza, J.L., Giralt, M., Romeu, M., Domingo, J.L., Gomez, M. (2010) Protective role of melatonin on oxidative stress status of AβPP transgenic mice after chronic exposure to aluminum. Biol. Trace Elem. Res., 35, 220-232.
73. Garcia, T., Esparza, J.L., Nogues, M.R., Romeu, M., Domingo, J.L., Gomez, M. (2010) Oxidative stress status and RNA expression in hippocampus of an animal model of Alzheimer's disease after chronic exposure to melatonin. Hippocampus, 20, 218-225.
74. Garcia, T., Ribes, D., Colomina, M.T., Cabre, M., Domingo, J.L., Gomez, M. (2009) Evaluation of the protective role of melatonin on the behavioral effects of aluminum in a mouse model of Alzheimer's disease. Toxicology, 265, 49-55.
75. Gibb, J.W., Bush, L., Hanson, G.R. (1997) Exacerbation of methamphetamine-induced neurochemical deficits by melatonin. J. Pharmacol. Exp. Ther., 283, 630-635.
76. Gilad, E., Cuzzocrea, S., Zingarella, B., Salzman, A.L., Szabo, C. (1997) Melatonin is a scavenger of peroxynitrite. Life Sci., 60, PL169-PL174.
77. Gil-Mohapel, J., Simpson, J.M., Titterness, A.K., Christie, B.R. (2010) Characterization of the neurogenesis quiescent zone in the rodent brain: effects of age and exercise. Eur. J. Neurosci., 31, 797-807.
78. Giordano, G., White, C.C., Mohar, I., Kavanagh, T.J., Costa, L.G. (2007) Glutathione levels modulate domoic acid induced apoptosis in mouse cerebellar granule cells. Toxicol. Sci., 10, 433-444.
79. Gitto, E., Pelligrino, S., Gitto, P., Barberi, I., Reiter, R.J. (2009) Oxidative stress of the newborn in the pre-and postnatal period and the clinical utility of melatonin. J. Pineal Res., 46, 123-129.
80. Gomez, M., Esparza, J.L., Nogues, M.R., Giralt, M., Cabre, M., Domingo, J.L. (2005) Pro-oxidant activity of aluminum in the rat hippocampus: gene expression of antioxidant enzymes after melatonin administration. Free Radic. Biol. Med., 38, 104-111.
81. Guenther, A.L., Schmidt, S.I., Laatsch, H., Fotso, S., Ness, H., Ressmeyer, A.R., Poeggeler, B., Hardeland, R. (2005) Reactions of the melatonin metabolite AMK (N1-acetyl-5-methoxykynuramine) with reactive nitrogen species: formation of novel compounds, 3-aceto-amidomethyl-6-methoxycinnolinone and 3-nitro-AMK. J. Pineal Res., 39, 251-260.
82. Guerrero, J.M., Reiter, R.J. (2002) Melatonin-immune system relationships. Curr. Top. Med. Chem., 2, 167-180.
83. Giusti, P., Franceschini, D., Petrone, M., Manev, H., Floreani, M. (1996) In vitro and in vivo protection against kainate-induced excitotoxicity by melatonin. J. Pineal Res., 20, 226-231.
84. Giusti, P., Gusella, M., Lipartiti, M., Milani, D., Zhu, w., Vicini, S., Manev, H. (1995) Melatonin protects primary cultures of cerebellar granule neurons from kainate but not from N-methyl-D-aspartate excitotoxicity. Exp. Neurol., 131, 39-46.
85. Giusti, P., Lipartiti, M., Franceschini, D., Schiavo, N., Floreani, M., Manev, H. (1996) Neuroprotection by melatonin from kainateinduced excitotoxicity in rats. FASEB J., 10, 891-896.
86. Halliwell, B. (2007) Biochemistry of oxidative stress. Biochem. Soc. Trans., 35(PT5), 1147-1150.
87. Hara, M., Abe, M., Suzuki, T., Reiter, R.J. (1996) Tissue changes in glutathione metabolism and lipid peroxidation by swimming are partially prevented by melatonin. Pharmacol. Toxicol., 78, 308-312.
88. Hardeland, R. (2005) Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine, 27, 119-130.
89. -) with the melatonin metabolite N1-acetyl-5-methoxykynuramine. J. Pineal Res., 43, 382-388.
90. Hardeland, R., Balzer, I., Poeggeler, B., Fuhrberg, B., Una, H., Behrmann, G., Wolf, R., Meyer, T.J., Reiter, R.J. (1995) On the primary functions of melatonin in evolution: mediation of photoperodic signals in a unicells, photooxidation and scavenging of free radicals. J. Pineal Res., 18, 104-111.
91. Hardeland, R., Fuhrberg, B. (1996) Ubiquitous melatonin - presence and effects in unicells, plants and animals. Trends Comp. Biochem. Physiol., 2, 25-45.
92. Hardeland, R., Poeggeler, B. (2003) Non-vertebrate melatonin. J. Pineal Res., 34, 233-241.
93. Hardeland, R., Tan, D.X., Reiter, R.J. (2009) Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J. Pineal Res., 47, 109-126.
94. Hattori, A., Migitaka, H., Iigo, M., Itoh, M., Yamamoto, K., Ohtani-Kaneko, R., Hara, M., Suzuki, T., Reiter, R.J. (1995) Identification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebrates. Biochem. Mol. Biol. Int., 35, 627-634.
95. Hermes-Lima, M., Castillo, R.F., Valle, V.G.R., Bechara, E. J. H., Vercesi, A.E. (1992) Calcium-dependent mitochondrial oxidative damage promoted by 5-aminolevulinic acid. Biochem. Biophys. Acta., 116, 201-206.
96. Hermes-Lima, M., Valle, V.G.R., Vercesi, A.E., Bechara, E.J.H. (1991) Damage to the rat liver mitochondria promoted by δ-aminolevulinic acid-generated reactive oxygen species: corrections with acute intermittent porphysia and lead poisoning. Biochem. Biophys. Acta., 1056, 57-63.
97. Hill, S.M., Frasch, T., Xiang, S., Yuan, L., Duplessis, T., Mao, L. (2009) Molecular mechanisms of melatonin anticancer effects. Integr. Cancer Ther., 8, 337-346.
98. Hirata, H., Asanuma, M., Cadet, J.L. (1998) Melatonin attenuates methamphetamine-induced toxic effects of dopamine and serotonin terminals in mouse brain. Synapse, 30, 150-155.
99. Hirata, H., Ladenheim, B., Rothman, R.B., Epstein, C., Cadet, J.L. (1995) Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals. Brain Res., 677, 345-347.
100. Hotchkiss, A.J., Gibb, J.W. (1980) Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase in rat brain. J. Pharmacol. Exp. Ther., 214, 257-262.
101. Imam, S.Z., El-Yazal, J., Newport, G.D., Itzhak, Y., Cadet, J.L., Slikker, W., Jr., Ali, S.F. (2001) Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts. Ann. N.Y. Acad. Sci., 939, 366-380.
102. Imbesi, M., Arsian, A.D., Yildiz, S., Sharma, R., Gavin, P., Tun, N., Manev, H., Uz, T. (2009) The melatonin receptor M1 is re quired to the differential regulatory actions of melatonin on neural "clock" gene expression in striatal neurons in vitro. J. Pineal Res., 46, 87-94.
103. Ito, Y., Niiya, Y., Kurita, H., Shima, S., Sarai, S. (1985) Serum lipid peroxide level and blood superoxide dismutase activity in workers with occupational exposure to lead. Int. Arch. Occup. Environ. Health, 56, 119-127.
104. Itzhak, Y., Martin, J.L., Black, M.D., Ali, S.F. (1998) Effect of melatonin on methamphetamine and 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavior sensitization. Neuropharmacology, 37, 781-791.
105. Jan, J.E., Wasdell, M.B., Reiter, R.J., Weiss, M.D., Johnson, K.P., Ivanenko, A., Freeman, R.P. (2007) Melatonin therapy of pediatric sleep disorders: recent advances, why it works, who are the candidates and how to treat. Curr. Pediatr. Res., 3, 214-224.
106. Jarzynka, M.J., Passey, D.X., Johnson, D.A., Konduru, N.V., Fitz, N.F., Radio, N.M., Rasenick, M., Benloucif, S., Melan, M.A., Witt-Enderby, P.A. (2009) Microtubules modulate melatonin receptors involved in phase-shifting circadian activity rhythms: in vitro and in vivo evidence. J. Pineal Res., 46, 161-171.
107. Joo, W.S., Jin, B.K., Park, C.W., Maeng, S.H., Kim, Y.S. (1998) Melatonin increases striatal dopaminergic function in 6-OHDAlesioned rats. Neuroreport, 9, 4123-4126.
108. Jou, J.J., Peng, T.I., Reiter, R.J., Jou, S.B., Wu, H.Y., Wen, S.T. (2004) Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes. J. Pineal Res., 37, 55-70.
109. Jou, M.J., Peng, T.I., Yu, P.Z., Wu, H.Y., Reiter, R.J., Hsu, L.F. (2007) Melatonin protects against common deletion of mitochondrial DNA-augmented mitochondrial oxidative stress and apoptosis. J. Pineal Res., 43, 389-403.
110. Jung-Hynes, B., Reiter, R.J., Ahmad, N. (2009) Sirtuins, melatonin and circadian rhythm: building a bridge between aging and cancer. J. Pineal Res., 48, 9-19.
111. Kaewsuk, S., Sae-ung, K., Phansuwan-Pujito, P., Govitrapong, P. (2009) Melatonin attenuates methamphetamine-induced reduction of tyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in the neonatal rat brain. Neurochem. Int., 55, 397-405.
112. Kennaway, D.J., Wright, H. (2002) Melatonin and circadian rhythms. Curr. Top. Med. Chem., 2, 199-209.
113. Kennedy, S.H., Rizvi, S.J. (2009) Emerging drugs for major depression disorders. Expert Opin. Emerg. Drugs, 14, 439-453.
114. Kim, M.J., Kim, H.K., Kim, B.S., Yim, S.V. (2004) Melatonin increases cell proliferation in the dentate gyrus of maternally separated rats. J. Pineal Res., 37, 193-197.
115. Kim, Y.S., Joo, W.S., Lin, B.K., Cho, Y.H., Baik, H.H., Park, C.W. (1998) Melatonin protects 6-OHDA-induced neuronal death nigrostriatal dopaminergic system. Neuroreport, 9, 2387-2390.
116. Koda, L.Y., Gibb, J.W. (1973) Adrenal and striatal tyrosine hydroxylase activity after methamphetamine. J. Pharmacol. Exp. Ther., 185, 42-42.
117. Kongsuphol, P., Mukda, S., Nopparat, C., Villaroel, A., Govitrapong, P. (2009) Melatonin attenuates methamphetamineinduced deactivation of the mammalian target of rapamycin signaling to induce autophagy in SK-N-SH cells. J. Pineal Res., 46, 199-206.
118. Konturek, P.C., Konturek, S.J., Celinski, K., Slomka, M., Cichoz-Lach, H., Bielanski, W., Reiter, R.J. (2010) Role of melatonin in mucosal gastroprotection against aspirin-induced gastric lesions in humans. J. Pineal Res., 48, 318-323.
119. Korkmaz, A., Reiter, R.J., Topal, T., Manchester, L.C. Oter, S., Tan, D.X. (2009) Melatonin, an established antioxidant worthy of use in clinical trials. Mol. Med., 15, 43-50.
120. Korkmaz, A., Sanchez-Barcelo, A., Tan, D.X., Reiter, R.J. (2009) Role of melatonin in the epigenetic regulation of breast cancer. Breast Cancer Res. Treat., 115, 13-27.
121. Kovachich, G.B., Aronson, C.E., Brunswick, D.J. (1989) Effects of high-dose methamphetamine administration on serotonin transporters in rat brain using [3H] cyanoimipramine autoradiography. Brain Res., 505, 123-129.
122. Krewski, D., Yokel, R.A., Nieboer, E., Borchelt, D., Cohen, J., Harry, J., Kacew, S., Lindsay, J., Mahfouz, A.M., Rondeau, V. (2007) Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. J. Toxicol. Environ. Health B. Crit. Rev., 1, 1-269.
123. Kulkami, S.K., Dhir, A. (2009) Current investigational drugs for major depression. Expert Opin. Investig. Drugs, 18, 767-788.
124. Lack, B., Doya, S., Nyokong, T. (2001) Interaction of serotonin and melatonin with sodium, potassium, calcium, lithium and aluminum. J. Pineal Res., 31, 102-108.
125. Lazar, R.B., Ho, S.U., Melen, O., Daghestani, A.N. (1983) Multifocal central nervous system damage caused by toluene abuse. Neurology, 33, 1337-1340.
126. Lee, S.H., Chun, W., Kong, P.J., Han, J.A., Cho, B.P., Kwon, O.Y., Lee, H.J., Kim, S.S. (2006) Sustained activation of Akt by melatonin contributes to the protection against kainic acid-induced neuronal death in hippocampus. J. Pineal Res., 40, 79-85.
127. Lee, Y.D., Kim, J.Y., Lee, K.H., Kwak, Y.J., Lee, S.K., Kim, O.S., Song, D.Y., Lee, J.H., Baik, T.K., Kim, B.J., Kim, J.Y., Baik, H.W. (2009) Melatonin attenuates lipopolysaccharide-induced acute lung inflammation in sleep-deprived mice. J. Pineal Res., 46, 53-57.
128. Leon, J., Acuna-Castroviejo, D., Escames, G., Tan, D.X., Reiter, R.J. (2005) Melatonin mitigates mitochondrial malfunction. J. Pineal Res., 38, 1-9.
129. Leon, J., Escames, G., Rodriguez, M.I., Lopez, L.C., Tapias, V., Enterna, A., Camacho, E., Gallo, M.A., Espinosa, A., Tan, D.X., Reiter, R.J., Acuna-Castroviejo, D. (2006) Inhibition of neuronal nitric oxide synthase activity by N1-acetyl-5-methoxykynuramine, a brain metabolite of melatonin. J. Neurochem., 98, 2023-2033.
130. Leston, J., Harthe, C., Brun, J., Mottolese, C., Mertens, P., Sindou, M., Claustrat, B. (2010) Melatonin is released in the third ventricle in humans: a study in movement disorders. Neurosci. Lett., 469, 294-297.
131. Limson, J., Nyokong, T., Daya, S. (1998) The interaction of melatonin and its precursors with aluminum, cadmium, copper, iron, lead and zinc: an absorptive voltametric study. J. Pineal Res., 24, 15-21.
132. Lin, A.M.Y., Feng, S.F., Chao, P.L., Yang, C.H. (2009) Melatonin inhibits arsenite-induced peripheral neurotoxicity. J. Pineal Res., 46, 64-70.
133. Lin, C.H., Huang, J.Y., Ching, C.H., Chuang, J.I. (2008) Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats. J. Pineal Res., 44, 205-213.
134. Lincoln, G.A. (2002) Neuroendocrine regulation of seasonal gonadotrophin secretion and prolactin rhythms: lessons from the Soay ram model. Reproduction, 59 (Suppl.), 131-147.
135. Lopez, A., Garcia, J.A., Escames, G., Venegas, C., Ortiz, F., Lopez, L.C., Acuna-Castroviejo, D. (2009) Melatonin protects the mitochondria from oxidative damage reducing oxygen consumption, membrane potential, and superoxide anion production. J. Pineal Res., 46, 188-198.
136. Lopez-Burillo, S., Tan, D.X., Mayo, J.C., Sainz, R.M., Manchester, L.C., Reiter, R.J. (2003) Melatonin, xanthurenic acid, resveratrol, EGCG, vitamin C and alpha-lipoic acid differentially reduces oxidative DNA damage induced by Fenton reagents: a study of their individual and synergistic actions. J. Pineal Res., 34, 269-277.
137. Lopez-Burrillo, S., Tan, D.X., Rodriguez-Gallego, V., Manchester, L.C., Mayo, J.C., Sainz, R.M., Reiter, R.J. (2003) Melatonin and its derivatives cyclic 3-hydroxymelatonin, N1-acetyl-N2-formyl-5-methoxykynuramine and 6-hydroxymelatonin reduce DNA oxidative damage induced by Fenton reagents. J. Pineal Res., 34, 178-184.
138. Maharaj, D.S., Maharaj, H., Daya, S., Glass, B.D. (2006) Melatonin and 6-hydroxymelatonin protect against iron-induced neurotoxicity. J. Neurochem., 96, 78-81.
139. Maharaj, H., Sukhdev Maharaj, D., Scheepers, M., Mokokong, R., Daya, S. (2005) L-DOPA administration enhances 6-hydroxydopamine generation. Brain Res., 1063, 180-186.
140. Maldonado, M.D., Perez-San Gregorio, M.A., Reiter, R.J. (2009) The role of melatonin in the immune-neuro-psychology of mental disorders. Rec. Patents CNS Drug Disc., 4, 61-69.
141. Manchester, L.C., Poeggeler, B., Alvarez, F.L., Ogden, G.B., Reiter, R.J. (1995) Melatonin immunoreactivity in the photosynthetic prokaryote Rhodospirillum rubrum: implications for an ancientantioxidant system. Cell. Mol. Biol. Res., 41, 391-395.
142. Manchester, L.C., Tan, D.X., Reiter, R.J., Park, W., Monis, K., Qi, W. (2000) High levels of melatonin in the seeds of edible plants: possible function in germ tissue protection. Life Sci., 67, 3023-3029.
143. Manda, K., Reiter, R.J. (2009) Melatonin maintains adult hippocampal neurogenesis and cognitive functions after irradiation. Prog. Neurobiol., 90, 60-68.
144. Manda, K., Ueno, M. Anzai, K. (2007) AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J. Pineal Res., 42, 386-393.
145. Manev, H., Uz, T., Kharlamov, A., Joo, J.Y. (1996) Increased brain damage after stroke or excitotoxic seizures in melatonin-deficient rats. FASEB J., 10, 1546-1551.
146. Marino, A., Di Paolo, R., Cristafulli, C., Mazzon, E., Morabito, R., Paterniti, I., Galuppo, M., Genovese, T., La Spada, G., Cuzzocrea, S. (2009) Protective effect of melatonin against the inflammatory response elicited by crude venom from isolated nematocysts of Pelagia noctiluca (Cnidaria, Scyphozoa). J. Pineal Res., 47, 56-69.
147. Martin, M., Macias, M., Escames, G., Leon, J., Acuna-Castroviejo, D. (2000) Melatonin, but not vitamins C and E maintains glutathione homeostasis in t-butyl-hydroperoxide-induced mitochondrial oxidative damage. FASEB J., 14, 1677-1679.
148. Martinez-Cayuela, M. (1995) Oxygen free radicals and human disease. Biochimie, 77, 147-161.
149. Matuszak, Z., Bilska, M.A., Reszka, K.J., Chignell, C.F., Bilski, P. (2003) Interaction of molecular oxygen with melatonin and related indoles. Photochem. Photobiol., 78, 449-455.
150. Matuszak, Z., Reszka, K. Chignell, C.F. (1997) Reaction of melatonin and related indoles with hydroxyl radicals: EPR and spin trapping investigations. Free Radic. Biol. Med., 23, 367-372.
151. Mayo, J.C., Sainz, R.M., Antonlin, I., Rodriguez, C. (1999) Ultrastructural confirmation of neuronal protection by melatonin against the neurotoxin 6-hydroxydopamine cell damage. Brain Res., 818, 221-227.
152. Mayo, J.C., Sainz, R.M., Uria, H., Antonlin, I., Esteban, M.M., Rodriquez, C. (1998) Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells: complications for Parkinson's disease. J. Pineal Res., 24, 79-192.
153. Mayo, J.C., Sainz, R.M., Tan, D.X., Antolin, I., Rodriguez, C., Reiter, R.J. (2005) Melatonin and Parkinson's disease. Endocrine, 27, 169-178.
154. Melchiorri, D., Reiter, R.J., Sewerynek, F. (1995) Melatonin reduces kainate-induced lipid peroxidation in homogenates of different brain regions. FASEB J., 9, 1205-1210.
155. Mizoroki, T., Meshitsuka, S., Maeda, S., Murayama, M., Sahara, A., Tukashima, A. (2007) Aluminum induces tau aggregation in vitro but not in vivo. J. Alzheimers Dis., 11, 419-427.
156. Mohanan, P.V., Yamamoto, H.A. (2002) Preventive effect of melatonin against brain mitochondria DNA damage, lipid peroxidation and seizures induced by kainic acid. Toxicol. Lett., 129, 99-105.
157. Morera, A.L., Abreu, P. (2006) Seasonality of psychopathology and circannual melatonin rhythm. J. Pineal Res., 41, 284-287.
158. Munoz-Hoyos, A., Sanchez-Forte, M., Molina-Carballo, A., Escames, G., Martin-Medina, E., Reiter, R.J., Molina-Font, J.A., Acuna-Castroviejo, D. (1998) Melatonin's role as an anticonvulsant and neuronal protector: experimental and clinical evidence. J. Child Neurol., 13, 501-509.
159. Murch, S.J., Alan, A.R., Cao J., Saxena, P.K. (2009) Melatonin and serotonin in flowers and fruits of Datura metel L. J. Pineal Res., 47, 277-285.
160. Nagakawa, H., Sumiki, E., Takusagawa, M., Ikota, N., Matsushima, Y., Ozawa, T. (2000) Scavengers of peroxynitrite: inhibition of tyrosine nitration and oxidation with tryptamine derivatives, alpha-lipoic acid and synthetic compounds. Chem. Pharm. Bull., 48, 261-265.
161. Noda, Y., Mori, A., Liburty, R., Parker, L. (1999) Melatonin and its precursor scavenge nitric oxide. J. Pineal Res., 27, 159-163.
162. Okazaki, M., Ezura, H. (2009) Profiling of melatonin in the model tomato (Solanum lycopersicum L.) cultivar Micro-Tom. J. Pineal Res., 46, 338-343.
163. Olanow, C.W., Schapira Anthony, H.V. (1997) Neuroprotection in Parkinson's disease. In: Bar, P.R., Beal, M.F. (Eds.), Neuroprotection in CNS Disease, Marcel Dekker, New York, pp. 425-445.
164. Olcese, J.M., Cao, C., Mori, T., Mamcarz, M.B, Maxwell, A., Runfeldt, M.J., Wang L., Zhang, C., Lin, X., Zhang, G., Arendash, G.W. (2009) Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in transgenic model of Alzheimer disease. J. Pineal Res., 47, 82-96.
165. Olivieri, G., Hess, C., Savaskan, E., Ly, C., Meier, F., Baysang, G., Brockhaus, M., Müller-Spahn, F. (2001) Melatonin protects SHSY5Y neuroblastoma cells from cobalt-induced oxidative stress, neurotoxicity and increased β-amyloid secretion. J. Pineal Res., 31, 320-325.
166. Olney, J.W., Rhee, V., Ho, O.L. (1974) Kainic acid: a powerful neurotoxic analogue of glutamate. Brain Res., 77, 507-512.
167. Ortega-Gutierrez, S., Fuentes-Broto, L., Garcia, J.J., Lopez-Vincente, M., Martinez-Ballarin, E., Miana-Mena, F.J., Millan-Plano, S., Reiter, R.J. (2007) Melatonin reduces protein and lipid oxidative damage induced by homocysteine in rat brain homogenates. J. Cell. Biochem., 102, 729-735.
168. Pablos, M.I., Agapito, M.T., Gutierrez, R., Recio, J.M., Reiter, R.J., Barlow-Walden, L.R., Acuna-Castroviejo, D., Menendez-Pelaez, A. (1995) Melatonin stimulates the activity of the detoxifying enzyme glutathione peroxidase in several tissues of chicks. J. Pineal Res., 19, 111-115.
169. Pablos, M.I., Chuang, J.I., Reiter, R.J., Ortiz, G.G., Daniels, W.M.V., Sewerynek, E., Melchiorri, D., Poeggeler, B. (1995) Time course of melatonin-induced increase in glutathione peroxidase activity in chick tissues. Biol. Signals, 4, 325-330.
170. Pappolla, M.A., Chyan, Y.J., Poeggeler, B., Frangione, B., Wilson G., Ghiso, J., Reiter, R.J. (2000) An assessment of the antioxidant and antiamyloidogenic properties of melatonin: implications for Alzheimer's disease. J. Neural Transm., 107, 203-231.
171. Paradies, G., Petrosilla, G., Paradies, V., Reiter, R.J., Ruggiero, F.M. (2010) Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J. Pineal Res., 48, 297-310.
172. Paredes, S.D., Korkmaz, A., Manchester, L.C., Tan, D.X., Reiter, R.J. (2009) Phytomelatonin: a review. J. Exp. Bot., 60, 57-69.
173. Pascual, R., Zamora-Leon, S.P., Perez, N., Rojas, T., Rojo, A., Salinas, M.J., Reyes, A., Bustamante, C. (2010) Melatonin ameliorates neocortical dendritic impairment induced by toluene inhalation in the rat. Exp. Toxicol. Pathol., in press.
174. Peled, N., Shorer, Z., Peled, E., Pilar, G. (2001) Melatonin effect on seizures in children with severe neurological deficit disorders. Epilepsia, 42, 1208-1210.
175. Peters, J.L., Cassone, V.M. (2005) Melatonin regulates circadian electroretinogram rhythms in a dose-and time-dependent manner. J. Pineal Res., 38, 209-215.
176. Peyrot, F., Ducrocq, C. (2008) Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species. J. Pineal Res., 45, 235-246.
177. Poeggeler, B. (2005) Melatonin, aging, and age-related diseases: perspectives for prevention, intervention and therapy. Endocrine, 27, 201-212.
178. Poeggeler, B., Reiter, R.J., Tan, D.X., Chen, L.D., Manchester, L.C. (1993) Melatonin, hydroxyl radical-mediated oxidative damage and aging: a hypothesis. J. Pineal Res., 14, 151-168.
179. Posmyk, M.M., Balabusta, M., Wieczorek, M., Sliwinska, E., Janas, K.M. (2009) Melatonin applied to cucumber (Cucumis sativus L.) seeds improves germination during chilling stress. J. Pineal Res., 46, 214-223.
180. Posmyk, M.M., Kuran, H., Marciniak, K., Javas, K.M. (2008) Presowing seed treatment with melatonin protects red cabbage seedlings against toxic copper ion concentrations. J. Pineal Res., 45, 24-31.
181. Pozo, D., Reiter, R.J., Calvo, J.R., Guerrero, J.M. (1997) Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. J. Cell. Biochem., 65, 430-442.
182. Princ, F.G., Juknat, A.A., Maxit, A.G., Cardalda, C., Battle, A. (1997) Melatonin's antioxidant protection against δ-aminolevulinic acid-induced oxidative damage in rat cerebellum. J. Pineal Res., 23, 40-46.
183. Princ, F.G., Maxit, A.G., Cardalda, C., Battle, A., Juknat, A.A. (1998) In vivo protection by melatonin against δ-aminolevulinic acid-induced damage and its antioxidant effect on the activity of haem enzymes. J. Pineal Res., 24, 1-8.
184. Puy, H. Deybach, J.C., Baudry, P., Callebert, J., Touitou, I., Nordmann, Y. (1993) Decreased nocturnal plasma melatonin levels in patients with recurrent acute intermittent phorphyria attacks. Life Sci., 53, 621-627.
185. Ramirez-Rodriguez, G., Klempin, F., Babu, H., Benitez-King, G., Kempermann, G. (2009) Melatonin modulates cell survival of new neurons in the hippocampus of adult mice. Neuropsychopharmacology, 34, 2180-2191.
186. Rao, M.V., Purohit, A., Patel, T. (2010) Melatonin protection on mercury-exerted brain toxicity in the rat. Drug Chem. Toxicol., 33, 209-216.
187. Reiter, R.J. (1973) Comparative physiology: pineal gland. Annu. Rev. Physiol., 35, 305-328.
188. Reiter, R.J. (1974) Circannual reproductive rhythms in mammals related to photoperiod and pineal function: a review. Chronobiologia, 1, 365-395.
189. Reiter, R.J. (1995) Oxidative processes and antioxidative defense mechanism in the aging brain. FASEB J., 9, 526-533.
190. Reiter, R.J. (1998) Oxidative damage in the central nervous system. Progr. Neurobiol., 56, 359-384.
191. Reiter, R.J. (2000) Melatonin: lowering the high price of free radicals. News Physiol. Sci., 15, 246-250.
192. Reiter, R.J., Benitez-King, G. (2009) Melatonin reduces neuronal loss and cytoskeletal deterioration: implications for psychiatry. Salud Mental, 32, 3-11.
193. Reiter, R.J., Craft, C.M., Johnson, Jr., J.E., King, T.S., Richardson, B.A., Vaughan, G.M., Vaughan, M.K. (1981) Age-associated reduction in nocturnal pineal melatonin levels in female rats. Endocrinology, 109, 1295-1297.
194. Reiter, R.J., Korkmaz, A., Paredes, S.D., Manchester, L.C., Tan, D.X. (2008) Melatonin reduces oxidative/nitrosative stress due to drugs, toxins, metals and herbicides. Neuroendocrinol. Lett., 29, 101-105.
195. Reiter, R.J., Manchester, L.C., Tan, D.X. (2005) Melatonin in walnuts: influence on melatonin levels and total antioxidant capacity of blood. Nutrition, 21, 920-924.
196. Reiter, R.J., Paredes, S.D., Korkmaz, A., Jou, M.J., Tan, D.X. (2008) Melatonin combats molecular terrorism at the mitochondrial level. Interdisc. Toxicol., 1, 137-149.
197. Reiter, R.J., Paredes, S.D., Manchester, L.C., Tan, D.X. (2009) Reducing oxidative/nitrosative stress: a new-discovered genre for melatonin. Crit. Rev. Biochem. Mol. Biol., 44, 175-200.
198. Reiter, R.J., Richardson, B.A., Johnson, L.Y., Ferguson, B.N., Dinh, D.T. (1980) Pineal melatonin rhythm: reduction in aging Syrian hamsters. Science, 210, 1372-1373.
199. Reiter, R.J., Tan, D.X., Erren, T.C., Fuentes-Broto, L., Paredes, S.D. (2009) Light-mediated perturbations of circadian timing and cancer risk: a mechanistic analysis. Integr. Cancer Ther., 8, 354-360.
200. Reiter, R.J., Tan, D.X., Korkmaz, A. (2009) The circadian melatonin rhythm and its modulation: possible impact on hypertension. J. Hypertens., 27 (Suppl. 6), S17-S20.
201. Reiter, R.J., Tan, D.X., Manchester, L.C., Paredes, S.D., Mayo, J.C., Sainz, R.M. (2009) Melatonin and reproduction revisited. Biol. Reprod., 81, 445-456.
202. Reiter, R.J., Tan, D.X., Manchester, L.C., Terron, M.P., Flores, L.J., Koppisetti, S. (2007) Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv. Med. Sci., 52, 11-28.
203. Reiter, R.J., Tan, D.X., Osuna, C., Gitto, E. (2000) Actions of melatonin in the reduction of oxidative stress: a review. J. Biomed. Res., 7, 444-458.
204. Reiter, R.J., Tan, D.X., Sainz, R.M., Mayo, J.L. (2002) Melatonin: reducing the toxicity and increasing the efficacy of drugs. J. Pharm. Pharmacol., 54, 1299-1321.
205. Rennie, K., De Butte, M., Pappas, B.A. (2009) Melatonin promotes neurogenesis in dentate gyrus in the pinealectomized rats. J. Pineal Res., 47, 313-317.
206. Ressmeyer, A.R., Mayo, J.M., Zelosko, V., Sainz, R.M., Tan, D.X., Poeggeler, B., Antolin, I., Zsizsik, B.K., Reiter, R.J., Hardeland, R. (2003) Antioxidant properties of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction. Redox Rept., 8, 205-213.
207. Ricaurte, G.A., Schuster, C.R., Seiden, L.S. (1980) Long-term effects of repeated methamphetamine administration on dopamine and serotonin neurons in the rat brain: regional study. Brain Res., 193, 153-163.
208. Rodriguez, C., Mayo, J.C., Sainz, R.M., Antolin, I., Herrera, F., Martin, V., Reiter, R.J. (2004) Regulation of antioxidant enzymes: a significant role for melatonin. J. Pineal Res., 36, 1-9.
209. Rosales-Corral, S., Reiter, R.J., Tan, D.X., Ortiz, G.G., Lopez-Armas, G. (2010) Function aspects of redox control during inflammation. Antioxid. Redox Signal., in press.
210. Rosales-Corral, S., Tan, D.X., Reiter, R.J., Valdivia-Velazquez, M., Martinez-Barboza, G., Acosta-Martinez, J.P., Ortiz, G.G. (2003) Orally administered melatonin reduces oxidative stress and proinflammatory cytokines induced by amyloid-β peptide in rat brain: a comparative, in vivo study versus vitamin C and E. J. Pineal Res., 35, 80-84.
211. Rosin, A. (2009) The long-term consequences of exposure to lead. Isr. Med. Assoc. J., 11, 689-694.
212. Sack, R.L, Lewy, A.J., Erb, D.I., Vollmer, W.M., Singer, C.M. (1986) Human melatonin production decreases with age. J. Pineal Res., 3, 379-388.
213. Samantaray, S., Das, A., Thakore, N.P., Matzelle, D.D., Ray, S.K., Reiter, R.J., Banik, N. (2009) Therapeutic potential of melatonin in traumatic central nervous system injury. J. Pineal Res., 47, 134-142.
214. Sanchez-Barcelo, E., Cos, S. Mediavilla, M.D., Martinez-Campa, C., Gonzalez, A., Alonso-Gonzalez, C. (2005) Melatonin-estrogen interactions in breast cancer. J. Pineal Res., 38, 217-222.
215. Sanders-Bush, E., Bushing, J.A., Sulser, F. (1972) Long-term effects of p-chloroamphetamine on tryptophan hydroxylase activity and on the levels of 5-hydroxytryptoamine and 5-hydroxyindolacetetic acid in brain. Eur. J. Pharmacol., 20, 385-388.
216. Saravanan, K., Sindhu, K., Mohanakumar, K.P. (2007) Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model. J. Pineal Res., 42, 247-253.
217. Schaefer, M., Hardeland, R. (2009) The melatonin metabolite N1-acetyl-5-methoxykynuramine is a potent singlet oxygen scavenger. J. Pineal Res., 46, 49-52.
218. Scheer, F.A., Van Montfrans, G.A., van Someren, E.J.W., Mairuhu, G., Buijs, R.M. (2004) Daily night time melatonin reduces blood pressure in male patients with essential hypertension. Hypertension, 43, 192-197.
219. Seiden, L.S., Commins, D.L, Vosmer, G., Axt, K., Marek, G. (1988) Neurotoxicity in dopamine and 5-hydroxytryptamine terminal fields: a regional analysis in nigrostriatal and mesolimbic projection. Ann. N.Y. Acad. Sci., 537, 161-172.
220. Sharma, R., McMillan, C.R., Niles, L.P. (2007) Neural stem cell transplantation and melatonin treatment in a 6-hydroxydopamine model of Parkinson's disease. J. Pineal Res., 43, 245-254.
221. Sharma, R., McMillan, C.R., Tenn, C.C., Niles, L.P. (2006) Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease. Brain Res., 1068, 230-236.
222. Sherer, T.B., Kim, J.H. Betarbet, R., Greenamyre, J.T. (2003) Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp. Neurol., 179, 9-16.
223. Signorini, C., Ciccoli, L., Leoncini, S., Carloni, S., Perrone, S., Comporti, M., Balduini, W., Buonocore, G. (2009) Free iron, total F2-isoprostanes and total F2-neuroprostances in a model of neonatal hypoxic-ischemic encephalopathy: neuroprotective effects of melatonin. J. Pineal Res., 46, 148-154.
224. Silva, S.O., Rodrigues, M.R., Cavalho, S.R., Catalani, L.H., Campa, A., Ximenes, V.F. (2004) Oxidation of melatonin and its catabolites N1-acetyl-N2-formyl-5-methoxykynuramine and N1-acetyl-5-methoxykynuramine, by activated leucocytes. J. Pineal Res., 37, 171-175.
225. Simko, F. Paulis, L. (2007) Melatonin as a potential antihypertensive treatment. J. Pineal Res., 42, 319-322.
226. Simko, F., Pechanova, O. (2009) Potential roles of melatonin and chronotherapy among the new trends in hypertension treatment. J. Pineal Res., 47, 127-133.
227. Skinner, D.C., Malpaux, B. (1999) High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus. Endocrinology, 140, 4399-4405.
228. Sliverman, P.B. (1993) On-off effects of dopamine receptor antagonists in the hemiparkinsonian rat. Eur. J. Pharmacol., 242, 31-36.
229. Solmaz, I., Gurkanlar, D., Goksoy, C., Ozkan, M., Erdogan, E. (2009) Antiepileptic activity of melatonin in guinea pigs with pentylenetetrazol-induced seizures. Neurol. Res., 31, 989-995.
230. Sotthibundhu, A., Phansuwan-Pujito, P., Govitrapong, P. (2010) Melatonin increases proliferation of cultured neural stem cells obtained from adult mouse subventricular zone. J. Pineal Res., in press.
231. Sperk, G. (1994) Kainic acid seizures in the rat. Prog. Neurobiol., 42, 1-32.
232. Stascia, P., Ulanski, P., Rosiak, J.M. (1998) Melatonin as a hydroxyl radical scavenger. J. Pineal Res., 25, 65-66.
233. Steranka, L.R., Sanders-Bush, E. (1980) Long-term effects of continuous exposure to amphetamine in brain dopamine concentration and synaptosomal uptake in mice. Eur. J. Pharmacol., 65, 439-443.
234. Suwanjang, W., Phansuwan-Pujito, P., Govitrapong, P., Chetsawang, B. (2010) The protective effect of melatonin on methamphetamine-induced calpain-dependent death pathway in human neuroblastoma SH-SY5Y cells. J. Pineal Res., 48, 94-101.
235. Tamarkin, L., Baird, C.J., Almeida, O.F. (1985) Melatonin a coordinating signal for mammalian reproduction? Science, 227, 714-720.
236. Tan, D.X., Chen, L.D., Poeggeler, B., Manchester, L.C., Reiter, R.J. (1993) Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocrine J., 1, 57-60.
237. Tan, D.X., Hardeland, R., Manchester, L.C., Paredes, S.D., Korkmaz, A., Sainz, R.M., Mayo, J.C., Fuentes-Broto, L., Reiter, R.J. (2009) The changing biological roles of melatonin during evolution: from an antioxidant to signals of darkness, sexual selection and fitness. Biol. Rev., in press.
238. Tan, D.X., Manchester, L.C., Reiter, R.J., Qi, W., Kim, S.J., El-Sokkary, G.H. (1998) Melatonin protects hippocampal neurons in vivo against kainic acid-induced damage in mice. J. Neurosci. Res., 31, 62-67.
239. Tan, D.X., Manchester, L.C., Hardeland, R., Lopez-Burillo, S., Mayo, J.C., Sainz, R.M., Reiter, R.J. (2003) Melatonin: a hormone, a tissue factor, an autocoid, a paracoid and an antioxidant vitamin. J. Pineal Res., 34, 75-78.
240. Tan, D.X., Manchester, L.C., Helton, P., Reiter, R.J. (2007) Phytoremediative capacity of plants enriched with melatonin. Plant Signal. Behav., 2, 514-516.
241. Tan, D.X., Manchester, L.C., Mascio, P.D., Martinez, G.R., Prado, F.M., Gulteken, F., Reiter, R.J. (2007) Novel rhythms of N1-acetyl-N2-formyl-5-methoxykynuramine and its precursor melatonin in water hyacinth: importance for phytoremediation. FASEB J., 21, 1724-1729.
242. Tan, D.X., Manchester, L.C., Reiter, R.J., Plummer, B.F., Hardies, L.J., Weintraub, S.T., Vijayalaxmi, Shepherd, A.M.M. (1999) A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of melatonin interaction with hydroxyl radicals. Biochem. Biophys. Res. Commun., 253, 614-620.
243. Tan, D.X., Manchester, L.C., Reiter, R.J., Plummer, B.F., Limson, J., Weintraub, S.T., Qi, W. (2000) Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Radic. Biol. Med., 29, 1177-1185.
244. Tan, D.X., Manchester, L.C., Terron, M.P., Flores, L.J., Reiter, R.J. (2007) One molecule many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J. Pineal Res., 42, 28-42.
245. Tan, D.X., Reiter, R.J., Manchester, L.C., Yan, M.T., El-Sawi, M., Sainz, R.M., Mayo, J.C., Kohen, R., Allegra, M., Hardeland, R. (2002) Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr. Top. Med. Chem., 2, 181-197.
246. Tapias, V., Cannon, J.R., Greenamyre, J.P. (2010) Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model. J. Neurosci. Res., 88, 420-427.
247. Thompson, C.M., Markesbury, W.R., Ehmann, W.D., Mao, Y.X., Vance, D.E. (1988) Regional brain trace-element studies in Alzheimer's disease. Neurotoxicology, 9, 1-8.
248. Tilden, A.R., Anderson, W.J., Hutchinson, V.H. (1994) Melatonin in two species of damselfly, Ischnura verticalis and Enallagma civile. J. Insect. Physiol., 40, 775-780.
249. Tocharus, J., Khonthun, C., Chongthammakun, S., Govitrapong, P. (2010) Melatonin attenuates methamphetamine-induced overexpression of pre-inflammatory cytokines in microglial cells. J Pineal Res, 48, 347-352.
250. Tomas-Zapico, C., Coto-Montes, A. (2005) A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J. Pineal Res., 39, 99-104.
251. Tricoire, H., Locatelli, A., Chemineau, P., Malpaux, B. (2002) Melatonin enters cerebrospinal fluid through the pineal recess. Endocrinology, 143, 184-190.
252. Urata, Y., Honma, S., Goto, S. (1999) Melatonin induces gammaglutamylcysteine synthase mediated by activator protein-1 in human vascular endothelial cells. Free Radic. Biol. Med., 27, 838-847.
253. Valko, M., Morris, H., Cronin, M.T. (2005) Metals, toxicity and oxidative stress. Curr. Med. Chem., 12, 1161-1208.
254. Velkov, Z.A., Velkov, Y.Zh., Galunska, B.T., Paskalav, D.N., Todger, A.V. (2009) Melatonin quantum-chemical and biochemical investigation of antioxidant activity. Eur. J. Med. Chem., 44, 2834-2839.
255. Venkataraman, P., Krishnamoorthy, G., Vengatesh, G., Srinivasan, N., Aruldhas, M.M., Arunakaran, J. (2008) Protective role of melatonin on PCB (Aroclor 1254) induced oxidative stress and changes in acetylcholine esterase and membrane bound ATPases in cerebellum, cerebral cortex and hippocampus of the adult rat brain. Int. J. Dev. Neurosci., 26, 585-591.
256. Venkataraman, P., Selvakumar, K., Krishnamoorthy, G., Muthusami, S., Rameshkumar, R., Prakash, S., Arunakaran, J. (2010) Effect of melatonin on PCB (Aroclor 1254) induced neuronal damage and changes in Cu/Zn superoxide dismutase and glutathione peroxidase-4 mRNA expression in cerebral cortex, cerebellum and hippocampus of adult rats. Neurosci. Res., 66, 189-197.
257. Verstraeten, S.V., Aimo, L., Oteiza, P.I. (2008) Aluminum and lead: molecular mechanisms of brain toxicity. Arch. Toxicol., 82, 789-802.
258. Villeda-Hernandez, J., Barroso-Moguel, R., Mendez-Armenta, M., Nava-Ruiz, C., Huerta-Romero, R., Riso, C. (2001) Enhanced brain regional lipid peroxidation in developing rats exposed to low level of lead acetate. Brain Res. Bull., 55, 247-251.
259. Vivien-Roels, B., Pevet, P. (1993) Melatonin: presence and formation in invertebrates. Experientia, 49, 642-647.
260. Wang, Z., Zhang, J., Liu, H., Huang, H., Wang, C., Shen, Y., Li, D., Jing, H. (2009) Melatonin, a potent regulator of hemeoxygenase-1, reduces cardiopulmonary bypass-induced renal damage in rats. J. Pineal Res., 46, 248-254.
261. Wasdell, M.B., Jan, J.E. Bomden, M.M., Freeman, R.D., Reitneld, W.J., Tai, J., Hamilton, D., Weiss, M.D. (2008) A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities. J. Pineal Res., 44, 57-64.
262. Wenstrup, D., Ehmann, W.D., Markesbery, W.R. (1990) Trace element imbalance in isolated subcellular fractions of Alzheimer's disease brains. Brain Res., 533, 125-131.
263. Winiarska, K., Fraczyk, T., Malinska, D., Drozak, J., Bryla, J. (2006) Melatonin attenuates diabetes-induced oxidative stress in rabbits. J. Pineal Res., 40, 168-176.
264. Wisessmith, W., Phansuwan-Pujito, P., Gorutrapong, P., Cheteawang, B. (2009) Melatonin reduces induction of Bax, caspase and cell death in methamphetamine-treated human neuroblastoma SH-SY5Y cultured cells. J. Pineal Res., 46, 433-440.
265. Yalcin, A., Kanit, L., Sozmen, E.Y. (2004) Altered gene expressions in rat hippocampus after kainate injection with or without melatonin pre-treatment. Neurosci. Lett., 359, 65-68.
266. Yamamoto, H., Mohanan, R.V. (2002) Melatonin attenuates brain mitochondria DNA damage induced by potassium cyanide in vivo and in vitro. Toxicology, 179, 29-36.
267. Yamamoto, H.A., Mohanan, P.V. (2003) Ganglioside GT1B and melatonin inhibit brain mitochondrial DNA damage and seizures induced by kainic acid in mice. Brain Res., 964, 100-106.
268. Yamamoto, H., Tang, H.W. (1996) Preventive effect of melatonin against cyanide-induced seizures and lipid peroxidation in mice. Neurosci. Lett., 207, 89-92.
269. Yamamoto, H., Tang, H.W. (1996) Antagonistic effect of melatonin against cyanide-induced seizures and acute lethality in mice. Toxicol. Lett., 87, 19-24.
270. Yerer, M.B., Aydogan, S., Yapiolar, H., Yalcin, O., Kuru, O., Baskurt, O.K. (2003) Melatonin increases glutathione peroxidase activity and deformability of erythrocytes in septic rats. J. Pineal Res., 35, 138-139.
271. Yeung Laiwah, A.C., Moore, M.R., Goldberg, A. (1987) Pathogenesis of acute porphyria. Q. J. Med., 63, 377-392.
272. Yon, J.H., Carter, L.B., Reiter, R.J., Jevtovic-Todoronic, V. (2006) Melatonin reduces the severity of anesthesia-induced apoptotic neurodegeneration in the developing rat brain. Neurobiol. Dis., 21, 522-530.
273. Zavodnik, I.B., Domanski, A.V., Lapshina, E.A., Bryszewska, M., Reiter, R.J. (2006) Melatonin directly scavenges peroxyl and alkoxyl radicals generated in red blood cells and a cell-free system: chemiluminescence measurements and theoretical calculations. Life Sci., 79, 391-400.
274. Zawilska, J.B., Skene, D.J., Arendt, J. (2009) Physiology and pharmacology of melatonin in relation to biological rhythms. Pharmacol. Rept., 61, 383-410.
275. Zhang, H., Squadrito, G.L., Pryor, W.A. (1998) The reaction of melatonin with peroxynitrite: formation of melatonin radical cation and absence of stable nitrated products. Biochem. Biophys. Res. Commun., 251, 83-87.
276. Zhang, H., Squadrito, G.L., Uppu, R., Pryor, W.A. (1999) Reaction of peroxynitrite with melatonin: a mechanistic study. Chem. Res. Toxicol., 12, 526-534.
277. Zhang, Y.M., Liu, X.Z., Mei, L., Liu, Z.P. (2009) Lipid peroxidation and ultrastructural modifications in brain after perinatal exposure to lead and/or cadmium in rat pups. Biomed. Environ. Sci., 22, 423-429.
278. Zhou, J.L., Zhu, X.G., Ling, Y.L., Li, Q. (2004) Melatonin reduces peroxynitrite-induced in aortic smooth muscle cells. Acta Pharmacol. Sin., 25, 186-190.